Sarah Welbourn
- Virology top 5%
- Epidemiology
- Molecular Biology
- Immunology
- Hepatology top 5%
- Co-authors
- Klaus StrebelArnim PauseO. John SemmesSucharita DuttaRachel BeckermanKarine AuclairEri MiyagiRalf Bartenschlager
- Topics
- HIV Research and Treatment (10 papers)Hepatitis C virus research (7 papers)Hepatitis B Virus Studies (6 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Sarah Welbourn
18 papers receiving 535 citations
Peers
Comparison fields: 5 of 64
- Virology 221
- Epidemiology 193
- Molecular Biology 158
- Immunology 143
- Hepatology 140
Countries citing papers authored by Sarah Welbourn
This map shows the geographic impact of Sarah Welbourn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Welbourn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Welbourn more than expected).
Fields of papers citing papers by Sarah Welbourn
This network shows the impact of papers produced by Sarah Welbourn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Welbourn. The network helps show where Sarah Welbourn may publish in the future.
Co-authorship network of co-authors of Sarah Welbourn
This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Welbourn. A scholar is included among the top collaborators of Sarah Welbourn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Welbourn. Sarah Welbourn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 4 | |
| 4 | 6 | |
| 5 | 12 | |
| 6 | 49 | |
| 7 | 21 | |
| 8 | 11 | |
| 9 | 7 | |
| 10 | 127 | |
| 11 | 29 | |
| 12 | 13 | |
| 13 | 39 | |
| 14 | 20 | |
| 15 | 0 | |
| 16 | 20 | |
| 17 | The hepatitis C virus NS2/3 protease. | 29 |
| 18 | HCV NS2/3 Protease | 3 |
| 19 | 53 | |
| 20 | 102 |
About Sarah Welbourn
Sarah Welbourn is a scholar working on Virology, Hepatology and Immunology, having authored 20 papers that have together received 550 indexed citations. Recurring topics across this work include HIV Research and Treatment (10 papers), Hepatitis C virus research (7 papers) and Hepatitis B Virus Studies (6 papers). The work is most often cited by research in Virology (221 citations), Hepatology (140 citations) and Complementary and alternative medicine (59 citations). Sarah Welbourn has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Klaus Strebel, Arnim Pause, O. John Semmes, Sucharita Dutta, Rachel Beckerman, Karine Auclair, Eri Miyagi, Ralf Bartenschlager, Karen Meerovitch and Philip R. Tedbury. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.